Neuroone Medical Technologies is trading at $1.06, up 10.26% after hours; no confirmed company-specific announcement explaining the rise was identified. - Shares closed the October 16 regular session at $0.96. - The preliminary fiscal 2026 revenue update and research-grant news were previously announced, not confirmed as new October 16 catalysts. - Broader-market reports described technology-led selling on October 16, which does not explain the after-hours gain; after-hours volume or activity details were not provided.